KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,802,352 | +23.4% | 2,809,577 | 0.0% | 0.28% | +22.7% |
| Q2 2023 | $39,558,844 | +31.3% | 2,809,577 | +0.4% | 0.23% | +39.6% |
| Q1 2023 | $30,123,449 | -28.2% | 2,799,577 | 0.0% | 0.16% | -34.9% |
| Q4 2022 | $41,937,663 | +16.7% | 2,799,577 | 0.0% | 0.25% | +7.2% |
| Q3 2022 | $35,947,000 | +32.5% | 2,799,577 | 0.0% | 0.24% | +52.6% |
| Q2 2022 | $27,128,000 | -2.5% | 2,799,577 | 0.0% | 0.15% | -3.8% |
| Q1 2022 | $27,828,000 | -15.5% | 2,799,577 | 0.0% | 0.16% | 0.0% |
| Q4 2021 | $32,951,000 | +3.3% | 2,799,577 | 0.0% | 0.16% | +14.3% |
| Q3 2021 | $31,887,000 | -18.2% | 2,799,577 | 0.0% | 0.14% | -18.1% |
| Q2 2021 | $38,998,000 | -24.7% | 2,799,577 | 0.0% | 0.17% | -24.0% |
| Q1 2021 | $51,820,000 | +4.8% | 2,799,577 | 0.0% | 0.22% | +21.0% |
| Q4 2020 | $49,469,000 | +15.3% | 2,799,577 | 0.0% | 0.19% | +8.8% |
| Q3 2020 | $42,890,000 | -39.9% | 2,799,577 | 0.0% | 0.17% | -45.7% |
| Q2 2020 | $71,333,000 | +64.6% | 2,799,577 | 0.0% | 0.32% | +18.0% |
| Q1 2020 | $43,337,000 | +40.0% | 2,799,577 | 0.0% | 0.27% | +61.8% |
| Q4 2019 | $30,963,000 | +30.0% | 2,799,577 | 0.0% | 0.16% | +1.9% |
| Q3 2019 | $23,824,000 | -37.1% | 2,799,577 | 0.0% | 0.16% | -37.2% |
| Q2 2019 | $37,906,000 | -30.0% | 2,799,577 | -6.7% | 0.26% | -25.6% |
| Q1 2019 | $54,180,000 | -35.7% | 3,000,000 | 0.0% | 0.35% | -49.7% |
| Q4 2018 | $84,270,000 | +10.2% | 3,000,000 | 0.0% | 0.69% | +36.9% |
| Q3 2018 | $76,500,000 | +47.0% | 3,000,000 | 0.0% | 0.50% | +28.9% |
| Q2 2018 | $52,050,000 | – | 3,000,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |